nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—Breast disorder—Methotrexate—psoriasis	0.00052	0.00052	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000517	0.000518	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Hydrocortisone—psoriasis	0.000517	0.000517	CcSEcCtD
Hydroxyurea—Malaise—Prednisolone—psoriasis	0.000515	0.000515	CcSEcCtD
Hydroxyurea—Discomfort—Mycophenolate mofetil—psoriasis	0.000515	0.000515	CcSEcCtD
Hydroxyurea—Oedema—Cyclosporine—psoriasis	0.000512	0.000512	CcSEcCtD
Hydroxyurea—Infection—Cyclosporine—psoriasis	0.000509	0.000509	CcSEcCtD
Hydroxyurea—Malaise—Hydrocortisone—psoriasis	0.000503	0.000503	CcSEcCtD
Hydroxyurea—Nervous system disorder—Cyclosporine—psoriasis	0.000502	0.000502	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Cyclosporine—psoriasis	0.000501	0.000501	CcSEcCtD
Hydroxyurea—Body temperature increased—Mycophenolic acid—psoriasis	0.0005	0.0005	CcSEcCtD
Hydroxyurea—Oedema—Mycophenolate mofetil—psoriasis	0.000499	0.0005	CcSEcCtD
Hydroxyurea—Skin disorder—Cyclosporine—psoriasis	0.000497	0.000498	CcSEcCtD
Hydroxyurea—Angiopathy—Dexamethasone—psoriasis	0.000496	0.000497	CcSEcCtD
Hydroxyurea—Angiopathy—Betamethasone—psoriasis	0.000496	0.000497	CcSEcCtD
Hydroxyurea—Infection—Mycophenolate mofetil—psoriasis	0.000496	0.000496	CcSEcCtD
Hydroxyurea—Convulsion—Prednisolone—psoriasis	0.000495	0.000495	CcSEcCtD
Hydroxyurea—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.00049	0.00049	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000489	0.000489	CcSEcCtD
Hydroxyurea—Anorexia—Cyclosporine—psoriasis	0.000488	0.000488	CcSEcCtD
Hydroxyurea—Pancreatitis—Methotrexate—psoriasis	0.000488	0.000488	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Triamcinolone—psoriasis	0.000487	0.000487	CcSEcCtD
Hydroxyurea—Skin disorder—Mycophenolate mofetil—psoriasis	0.000485	0.000485	CcSEcCtD
Hydroxyurea—Alopecia—Dexamethasone—psoriasis	0.000484	0.000484	CcSEcCtD
Hydroxyurea—Alopecia—Betamethasone—psoriasis	0.000484	0.000484	CcSEcCtD
Hydroxyurea—Convulsion—Hydrocortisone—psoriasis	0.000483	0.000483	CcSEcCtD
Hydroxyurea—Discomfort—Prednisolone—psoriasis	0.00048	0.00048	CcSEcCtD
Hydroxyurea—Haemoglobin—Prednisone—psoriasis	0.000479	0.000479	CcSEcCtD
Hydroxyurea—Haemorrhage—Prednisone—psoriasis	0.000477	0.000477	CcSEcCtD
Hydroxyurea—Erythema—Dexamethasone—psoriasis	0.000476	0.000477	CcSEcCtD
Hydroxyurea—Erythema—Betamethasone—psoriasis	0.000476	0.000477	CcSEcCtD
Hydroxyurea—Anorexia—Mycophenolate mofetil—psoriasis	0.000476	0.000476	CcSEcCtD
Hydroxyurea—Hallucination—Prednisone—psoriasis	0.000474	0.000474	CcSEcCtD
Hydroxyurea—Malaise—Triamcinolone—psoriasis	0.000473	0.000474	CcSEcCtD
Hydroxyurea—Pancytopenia—Methotrexate—psoriasis	0.000472	0.000473	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000471	0.000472	CcSEcCtD
Hydroxyurea—Discomfort—Hydrocortisone—psoriasis	0.000469	0.000469	CcSEcCtD
Hydroxyurea—Oedema—Prednisolone—psoriasis	0.000466	0.000466	CcSEcCtD
Hydroxyurea—Dysuria—Methotrexate—psoriasis	0.000465	0.000465	CcSEcCtD
Hydroxyurea—Neutropenia—Methotrexate—psoriasis	0.000465	0.000465	CcSEcCtD
Hydroxyurea—Dyspnoea—Cyclosporine—psoriasis	0.000456	0.000457	CcSEcCtD
Hydroxyurea—Somnolence—Cyclosporine—psoriasis	0.000455	0.000455	CcSEcCtD
Hydroxyurea—Oedema—Hydrocortisone—psoriasis	0.000455	0.000455	CcSEcCtD
Hydroxyurea—Convulsion—Triamcinolone—psoriasis	0.000455	0.000455	CcSEcCtD
Hydroxyurea—Asthenia—Mycophenolic acid—psoriasis	0.000454	0.000454	CcSEcCtD
Hydroxyurea—Infection—Hydrocortisone—psoriasis	0.000452	0.000452	CcSEcCtD
Hydroxyurea—Dyspepsia—Cyclosporine—psoriasis	0.000451	0.000451	CcSEcCtD
Hydroxyurea—Nervous system disorder—Hydrocortisone—psoriasis	0.000446	0.000446	CcSEcCtD
Hydroxyurea—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000445	0.000445	CcSEcCtD
Hydroxyurea—Decreased appetite—Cyclosporine—psoriasis	0.000445	0.000445	CcSEcCtD
Hydroxyurea—Somnolence—Mycophenolate mofetil—psoriasis	0.000444	0.000444	CcSEcCtD
Hydroxyurea—Drowsiness—Methotrexate—psoriasis	0.000444	0.000444	CcSEcCtD
Hydroxyurea—Infestation—Methotrexate—psoriasis	0.000444	0.000444	CcSEcCtD
Hydroxyurea—Infestation NOS—Methotrexate—psoriasis	0.000444	0.000444	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000442	0.000442	CcSEcCtD
Hydroxyurea—Skin disorder—Hydrocortisone—psoriasis	0.000442	0.000442	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Dexamethasone—psoriasis	0.000442	0.000442	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Betamethasone—psoriasis	0.000442	0.000442	CcSEcCtD
Hydroxyurea—Discomfort—Triamcinolone—psoriasis	0.000442	0.000442	CcSEcCtD
Hydroxyurea—Fatigue—Cyclosporine—psoriasis	0.000441	0.000442	CcSEcCtD
Hydroxyurea—Dyspepsia—Mycophenolate mofetil—psoriasis	0.00044	0.00044	CcSEcCtD
Hydroxyurea—Pain—Cyclosporine—psoriasis	0.000438	0.000438	CcSEcCtD
Hydroxyurea—Constipation—Cyclosporine—psoriasis	0.000438	0.000438	CcSEcCtD
Hydroxyurea—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000434	0.000434	CcSEcCtD
Hydroxyurea—Anorexia—Hydrocortisone—psoriasis	0.000434	0.000434	CcSEcCtD
Hydroxyurea—Diarrhoea—Mycophenolic acid—psoriasis	0.000433	0.000433	CcSEcCtD
Hydroxyurea—Stomatitis—Methotrexate—psoriasis	0.000432	0.000433	CcSEcCtD
Hydroxyurea—Angiopathy—Prednisone—psoriasis	0.000432	0.000433	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000431	0.000431	CcSEcCtD
Hydroxyurea—Malaise—Dexamethasone—psoriasis	0.00043	0.00043	CcSEcCtD
Hydroxyurea—Malaise—Betamethasone—psoriasis	0.00043	0.00043	CcSEcCtD
Hydroxyurea—Oedema—Triamcinolone—psoriasis	0.000428	0.000429	CcSEcCtD
Hydroxyurea—Pain—Mycophenolate mofetil—psoriasis	0.000427	0.000427	CcSEcCtD
Hydroxyurea—Constipation—Mycophenolate mofetil—psoriasis	0.000427	0.000427	CcSEcCtD
Hydroxyurea—Infection—Triamcinolone—psoriasis	0.000426	0.000426	CcSEcCtD
Hydroxyurea—Feeling abnormal—Cyclosporine—psoriasis	0.000422	0.000422	CcSEcCtD
Hydroxyurea—Alopecia—Prednisone—psoriasis	0.000421	0.000421	CcSEcCtD
Hydroxyurea—Hepatobiliary disease—Methotrexate—psoriasis	0.00042	0.00042	CcSEcCtD
Hydroxyurea—Dizziness—Mycophenolic acid—psoriasis	0.000418	0.000419	CcSEcCtD
Hydroxyurea—Erythema—Prednisone—psoriasis	0.000415	0.000415	CcSEcCtD
Hydroxyurea—Convulsion—Dexamethasone—psoriasis	0.000413	0.000413	CcSEcCtD
Hydroxyurea—Convulsion—Betamethasone—psoriasis	0.000413	0.000413	CcSEcCtD
Hydroxyurea—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000412	0.000412	CcSEcCtD
Hydroxyurea—Body temperature increased—Cyclosporine—psoriasis	0.000405	0.000405	CcSEcCtD
Hydroxyurea—Vomiting—Mycophenolic acid—psoriasis	0.000402	0.000403	CcSEcCtD
Hydroxyurea—Discomfort—Dexamethasone—psoriasis	0.000401	0.000401	CcSEcCtD
Hydroxyurea—Discomfort—Betamethasone—psoriasis	0.000401	0.000401	CcSEcCtD
Hydroxyurea—Dyspepsia—Hydrocortisone—psoriasis	0.000401	0.000401	CcSEcCtD
Hydroxyurea—Haemoglobin—Methotrexate—psoriasis	0.0004	0.0004	CcSEcCtD
Hydroxyurea—Rash—Mycophenolic acid—psoriasis	0.000399	0.000399	CcSEcCtD
Hydroxyurea—Dermatitis—Mycophenolic acid—psoriasis	0.000399	0.000399	CcSEcCtD
Hydroxyurea—Pain—Prednisolone—psoriasis	0.000398	0.000399	CcSEcCtD
Hydroxyurea—Haemorrhage—Methotrexate—psoriasis	0.000398	0.000398	CcSEcCtD
Hydroxyurea—Headache—Mycophenolic acid—psoriasis	0.000396	0.000397	CcSEcCtD
Hydroxyurea—Decreased appetite—Hydrocortisone—psoriasis	0.000396	0.000396	CcSEcCtD
Hydroxyurea—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000395	0.000395	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000393	0.000393	CcSEcCtD
Hydroxyurea—Fatigue—Hydrocortisone—psoriasis	0.000392	0.000392	CcSEcCtD
Hydroxyurea—Pain—Hydrocortisone—psoriasis	0.000389	0.000389	CcSEcCtD
Hydroxyurea—Oedema—Betamethasone—psoriasis	0.000389	0.000389	CcSEcCtD
Hydroxyurea—Oedema—Dexamethasone—psoriasis	0.000389	0.000389	CcSEcCtD
Hydroxyurea—Infection—Betamethasone—psoriasis	0.000386	0.000386	CcSEcCtD
Hydroxyurea—Infection—Dexamethasone—psoriasis	0.000386	0.000386	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Prednisone—psoriasis	0.000385	0.000385	CcSEcCtD
Hydroxyurea—Feeling abnormal—Prednisolone—psoriasis	0.000384	0.000384	CcSEcCtD
Hydroxyurea—Anaemia—Prednisone—psoriasis	0.000383	0.000384	CcSEcCtD
Hydroxyurea—Dyspnoea—Triamcinolone—psoriasis	0.000382	0.000382	CcSEcCtD
Hydroxyurea—Nervous system disorder—Betamethasone—psoriasis	0.000381	0.000381	CcSEcCtD
Hydroxyurea—Nervous system disorder—Dexamethasone—psoriasis	0.000381	0.000381	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Betamethasone—psoriasis	0.000381	0.000381	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Dexamethasone—psoriasis	0.000381	0.000381	CcSEcCtD
Hydroxyurea—Hypersensitivity—Cyclosporine—psoriasis	0.000377	0.000377	CcSEcCtD
Hydroxyurea—Dyspepsia—Triamcinolone—psoriasis	0.000377	0.000377	CcSEcCtD
Hydroxyurea—Nausea—Mycophenolic acid—psoriasis	0.000376	0.000376	CcSEcCtD
Hydroxyurea—Feeling abnormal—Hydrocortisone—psoriasis	0.000375	0.000375	CcSEcCtD
Hydroxyurea—Malaise—Prednisone—psoriasis	0.000374	0.000374	CcSEcCtD
Hydroxyurea—Anorexia—Dexamethasone—psoriasis	0.000371	0.000371	CcSEcCtD
Hydroxyurea—Anorexia—Betamethasone—psoriasis	0.000371	0.000371	CcSEcCtD
Hydroxyurea—Fatigue—Triamcinolone—psoriasis	0.000369	0.00037	CcSEcCtD
Hydroxyurea—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000368	0.000368	CcSEcCtD
Hydroxyurea—Asthenia—Cyclosporine—psoriasis	0.000367	0.000367	CcSEcCtD
Hydroxyurea—Pain—Triamcinolone—psoriasis	0.000366	0.000367	CcSEcCtD
Hydroxyurea—Angiopathy—Methotrexate—psoriasis	0.000361	0.000361	CcSEcCtD
Hydroxyurea—Body temperature increased—Hydrocortisone—psoriasis	0.00036	0.00036	CcSEcCtD
Hydroxyurea—Convulsion—Prednisone—psoriasis	0.000359	0.00036	CcSEcCtD
Hydroxyurea—Asthenia—Mycophenolate mofetil—psoriasis	0.000358	0.000358	CcSEcCtD
Hydroxyurea—Chills—Methotrexate—psoriasis	0.000357	0.000357	CcSEcCtD
Hydroxyurea—Feeling abnormal—Triamcinolone—psoriasis	0.000353	0.000353	CcSEcCtD
Hydroxyurea—Alopecia—Methotrexate—psoriasis	0.000352	0.000352	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000351	0.000351	CcSEcCtD
Hydroxyurea—Diarrhoea—Cyclosporine—psoriasis	0.00035	0.00035	CcSEcCtD
Hydroxyurea—Discomfort—Prednisone—psoriasis	0.000349	0.000349	CcSEcCtD
Hydroxyurea—Erythema—Methotrexate—psoriasis	0.000347	0.000347	CcSEcCtD
Hydroxyurea—Hypersensitivity—Prednisolone—psoriasis	0.000343	0.000343	CcSEcCtD
Hydroxyurea—Dyspepsia—Betamethasone—psoriasis	0.000342	0.000342	CcSEcCtD
Hydroxyurea—Dyspepsia—Dexamethasone—psoriasis	0.000342	0.000342	CcSEcCtD
Hydroxyurea—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000342	0.000342	CcSEcCtD
Hydroxyurea—Body temperature increased—Triamcinolone—psoriasis	0.000339	0.000339	CcSEcCtD
Hydroxyurea—Dizziness—Cyclosporine—psoriasis	0.000339	0.000339	CcSEcCtD
Hydroxyurea—Oedema—Prednisone—psoriasis	0.000339	0.000339	CcSEcCtD
Hydroxyurea—Decreased appetite—Betamethasone—psoriasis	0.000338	0.000338	CcSEcCtD
Hydroxyurea—Decreased appetite—Dexamethasone—psoriasis	0.000338	0.000338	CcSEcCtD
Hydroxyurea—Infection—Prednisone—psoriasis	0.000336	0.000336	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000336	0.000336	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Betamethasone—psoriasis	0.000336	0.000336	CcSEcCtD
Hydroxyurea—Hypersensitivity—Hydrocortisone—psoriasis	0.000335	0.000335	CcSEcCtD
Hydroxyurea—Fatigue—Betamethasone—psoriasis	0.000335	0.000335	CcSEcCtD
Hydroxyurea—Fatigue—Dexamethasone—psoriasis	0.000335	0.000335	CcSEcCtD
Hydroxyurea—Pain—Betamethasone—psoriasis	0.000332	0.000333	CcSEcCtD
Hydroxyurea—Pain—Dexamethasone—psoriasis	0.000332	0.000333	CcSEcCtD
Hydroxyurea—Nervous system disorder—Prednisone—psoriasis	0.000332	0.000332	CcSEcCtD
Hydroxyurea—Dizziness—Mycophenolate mofetil—psoriasis	0.00033	0.00033	CcSEcCtD
Hydroxyurea—Skin disorder—Prednisone—psoriasis	0.000329	0.000329	CcSEcCtD
Hydroxyurea—Asthenia—Hydrocortisone—psoriasis	0.000326	0.000327	CcSEcCtD
Hydroxyurea—Vomiting—Cyclosporine—psoriasis	0.000326	0.000326	CcSEcCtD
Hydroxyurea—Rash—Cyclosporine—psoriasis	0.000323	0.000323	CcSEcCtD
Hydroxyurea—Anorexia—Prednisone—psoriasis	0.000323	0.000323	CcSEcCtD
Hydroxyurea—Dermatitis—Cyclosporine—psoriasis	0.000323	0.000323	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Methotrexate—psoriasis	0.000322	0.000322	CcSEcCtD
Hydroxyurea—Headache—Cyclosporine—psoriasis	0.000321	0.000321	CcSEcCtD
Hydroxyurea—Anaemia—Methotrexate—psoriasis	0.00032	0.000321	CcSEcCtD
Hydroxyurea—Feeling abnormal—Dexamethasone—psoriasis	0.00032	0.00032	CcSEcCtD
Hydroxyurea—Feeling abnormal—Betamethasone—psoriasis	0.00032	0.00032	CcSEcCtD
Hydroxyurea—Vomiting—Mycophenolate mofetil—psoriasis	0.000318	0.000318	CcSEcCtD
Hydroxyurea—Hypersensitivity—Triamcinolone—psoriasis	0.000316	0.000316	CcSEcCtD
Hydroxyurea—Rash—Mycophenolate mofetil—psoriasis	0.000315	0.000315	CcSEcCtD
Hydroxyurea—Dermatitis—Mycophenolate mofetil—psoriasis	0.000315	0.000315	CcSEcCtD
Hydroxyurea—Headache—Mycophenolate mofetil—psoriasis	0.000313	0.000313	CcSEcCtD
Hydroxyurea—Malaise—Methotrexate—psoriasis	0.000313	0.000313	CcSEcCtD
Hydroxyurea—Diarrhoea—Hydrocortisone—psoriasis	0.000311	0.000311	CcSEcCtD
Hydroxyurea—Leukopenia—Methotrexate—psoriasis	0.00031	0.00031	CcSEcCtD
Hydroxyurea—Dizziness—Prednisolone—psoriasis	0.000308	0.000308	CcSEcCtD
Hydroxyurea—Asthenia—Triamcinolone—psoriasis	0.000307	0.000308	CcSEcCtD
Hydroxyurea—Body temperature increased—Dexamethasone—psoriasis	0.000307	0.000307	CcSEcCtD
Hydroxyurea—Body temperature increased—Betamethasone—psoriasis	0.000307	0.000307	CcSEcCtD
Hydroxyurea—Nausea—Cyclosporine—psoriasis	0.000304	0.000304	CcSEcCtD
Hydroxyurea—Dizziness—Hydrocortisone—psoriasis	0.000301	0.000301	CcSEcCtD
Hydroxyurea—Convulsion—Methotrexate—psoriasis	0.0003	0.0003	CcSEcCtD
Hydroxyurea—Dyspepsia—Prednisone—psoriasis	0.000298	0.000298	CcSEcCtD
Hydroxyurea—Nausea—Mycophenolate mofetil—psoriasis	0.000297	0.000297	CcSEcCtD
Hydroxyurea—Decreased appetite—Prednisone—psoriasis	0.000294	0.000294	CcSEcCtD
Hydroxyurea—Rash—Prednisolone—psoriasis	0.000294	0.000294	CcSEcCtD
Hydroxyurea—Dermatitis—Prednisolone—psoriasis	0.000293	0.000294	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000293	0.000293	CcSEcCtD
Hydroxyurea—Fatigue—Prednisone—psoriasis	0.000292	0.000292	CcSEcCtD
Hydroxyurea—Headache—Prednisolone—psoriasis	0.000292	0.000292	CcSEcCtD
Hydroxyurea—Discomfort—Methotrexate—psoriasis	0.000292	0.000292	CcSEcCtD
Hydroxyurea—Constipation—Prednisone—psoriasis	0.000289	0.00029	CcSEcCtD
Hydroxyurea—Vomiting—Hydrocortisone—psoriasis	0.000289	0.000289	CcSEcCtD
Hydroxyurea—Rash—Hydrocortisone—psoriasis	0.000287	0.000287	CcSEcCtD
Hydroxyurea—Dermatitis—Hydrocortisone—psoriasis	0.000287	0.000287	CcSEcCtD
Hydroxyurea—Headache—Hydrocortisone—psoriasis	0.000285	0.000285	CcSEcCtD
Hydroxyurea—Dizziness—Triamcinolone—psoriasis	0.000283	0.000283	CcSEcCtD
Hydroxyurea—Infection—Methotrexate—psoriasis	0.000281	0.000281	CcSEcCtD
Hydroxyurea—Feeling abnormal—Prednisone—psoriasis	0.000279	0.000279	CcSEcCtD
Hydroxyurea—Asthenia—Betamethasone—psoriasis	0.000279	0.000279	CcSEcCtD
Hydroxyurea—Asthenia—Dexamethasone—psoriasis	0.000279	0.000279	CcSEcCtD
Hydroxyurea—Nervous system disorder—Methotrexate—psoriasis	0.000277	0.000278	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Methotrexate—psoriasis	0.000277	0.000277	CcSEcCtD
Hydroxyurea—Nausea—Prednisolone—psoriasis	0.000277	0.000277	CcSEcCtD
Hydroxyurea—Skin disorder—Methotrexate—psoriasis	0.000275	0.000275	CcSEcCtD
Hydroxyurea—Vomiting—Triamcinolone—psoriasis	0.000272	0.000273	CcSEcCtD
Hydroxyurea—Nausea—Hydrocortisone—psoriasis	0.00027	0.00027	CcSEcCtD
Hydroxyurea—Rash—Triamcinolone—psoriasis	0.00027	0.00027	CcSEcCtD
Hydroxyurea—Dermatitis—Triamcinolone—psoriasis	0.00027	0.00027	CcSEcCtD
Hydroxyurea—Anorexia—Methotrexate—psoriasis	0.00027	0.00027	CcSEcCtD
Hydroxyurea—Headache—Triamcinolone—psoriasis	0.000268	0.000269	CcSEcCtD
Hydroxyurea—Body temperature increased—Prednisone—psoriasis	0.000268	0.000268	CcSEcCtD
Hydroxyurea—Diarrhoea—Dexamethasone—psoriasis	0.000266	0.000266	CcSEcCtD
Hydroxyurea—Diarrhoea—Betamethasone—psoriasis	0.000266	0.000266	CcSEcCtD
Hydroxyurea—Dizziness—Dexamethasone—psoriasis	0.000257	0.000257	CcSEcCtD
Hydroxyurea—Dizziness—Betamethasone—psoriasis	0.000257	0.000257	CcSEcCtD
Hydroxyurea—Nausea—Triamcinolone—psoriasis	0.000254	0.000255	CcSEcCtD
Hydroxyurea—Dyspnoea—Methotrexate—psoriasis	0.000252	0.000252	CcSEcCtD
Hydroxyurea—Somnolence—Methotrexate—psoriasis	0.000252	0.000252	CcSEcCtD
Hydroxyurea—Hypersensitivity—Prednisone—psoriasis	0.000249	0.00025	CcSEcCtD
Hydroxyurea—Dyspepsia—Methotrexate—psoriasis	0.000249	0.000249	CcSEcCtD
Hydroxyurea—Vomiting—Dexamethasone—psoriasis	0.000247	0.000247	CcSEcCtD
Hydroxyurea—Vomiting—Betamethasone—psoriasis	0.000247	0.000247	CcSEcCtD
Hydroxyurea—Decreased appetite—Methotrexate—psoriasis	0.000246	0.000246	CcSEcCtD
Hydroxyurea—Rash—Dexamethasone—psoriasis	0.000245	0.000245	CcSEcCtD
Hydroxyurea—Rash—Betamethasone—psoriasis	0.000245	0.000245	CcSEcCtD
Hydroxyurea—Dermatitis—Dexamethasone—psoriasis	0.000245	0.000245	CcSEcCtD
Hydroxyurea—Dermatitis—Betamethasone—psoriasis	0.000245	0.000245	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Methotrexate—psoriasis	0.000244	0.000244	CcSEcCtD
Hydroxyurea—Fatigue—Methotrexate—psoriasis	0.000244	0.000244	CcSEcCtD
Hydroxyurea—Headache—Betamethasone—psoriasis	0.000244	0.000244	CcSEcCtD
Hydroxyurea—Headache—Dexamethasone—psoriasis	0.000244	0.000244	CcSEcCtD
Hydroxyurea—Asthenia—Prednisone—psoriasis	0.000243	0.000243	CcSEcCtD
Hydroxyurea—Pain—Methotrexate—psoriasis	0.000242	0.000242	CcSEcCtD
Hydroxyurea—Feeling abnormal—Methotrexate—psoriasis	0.000233	0.000233	CcSEcCtD
Hydroxyurea—Diarrhoea—Prednisone—psoriasis	0.000232	0.000232	CcSEcCtD
Hydroxyurea—Nausea—Dexamethasone—psoriasis	0.000231	0.000231	CcSEcCtD
Hydroxyurea—Nausea—Betamethasone—psoriasis	0.000231	0.000231	CcSEcCtD
Hydroxyurea—Dizziness—Prednisone—psoriasis	0.000224	0.000224	CcSEcCtD
Hydroxyurea—Body temperature increased—Methotrexate—psoriasis	0.000224	0.000224	CcSEcCtD
Hydroxyurea—Vomiting—Prednisone—psoriasis	0.000215	0.000215	CcSEcCtD
Hydroxyurea—Rash—Prednisone—psoriasis	0.000213	0.000214	CcSEcCtD
Hydroxyurea—Dermatitis—Prednisone—psoriasis	0.000213	0.000213	CcSEcCtD
Hydroxyurea—Headache—Prednisone—psoriasis	0.000212	0.000212	CcSEcCtD
Hydroxyurea—Hypersensitivity—Methotrexate—psoriasis	0.000208	0.000209	CcSEcCtD
Hydroxyurea—Asthenia—Methotrexate—psoriasis	0.000203	0.000203	CcSEcCtD
Hydroxyurea—Nausea—Prednisone—psoriasis	0.000201	0.000201	CcSEcCtD
Hydroxyurea—Diarrhoea—Methotrexate—psoriasis	0.000194	0.000194	CcSEcCtD
Hydroxyurea—Dizziness—Methotrexate—psoriasis	0.000187	0.000187	CcSEcCtD
Hydroxyurea—Vomiting—Methotrexate—psoriasis	0.00018	0.00018	CcSEcCtD
Hydroxyurea—Rash—Methotrexate—psoriasis	0.000178	0.000178	CcSEcCtD
Hydroxyurea—Dermatitis—Methotrexate—psoriasis	0.000178	0.000178	CcSEcCtD
Hydroxyurea—Headache—Methotrexate—psoriasis	0.000177	0.000177	CcSEcCtD
Hydroxyurea—Nausea—Methotrexate—psoriasis	0.000168	0.000168	CcSEcCtD
Hydroxyurea—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	4.37e-05	0.1	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S-Specific Transcription—PCNA—psoriasis	4.19e-05	0.0963	CbGpPWpGaD
Hydroxyurea—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	4.08e-05	0.0937	CbGpPWpGaD
Hydroxyurea—CYP2D6—Xenobiotics—CYP2S1—psoriasis	2.71e-05	0.0623	CbGpPWpGaD
Hydroxyurea—RRM2—E2F mediated regulation of DNA replication—PCNA—psoriasis	2.46e-05	0.0567	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	1.8e-05	0.0414	CbGpPWpGaD
Hydroxyurea—RRM1—Nucleotide metabolism—CAT—psoriasis	1.75e-05	0.0401	CbGpPWpGaD
Hydroxyurea—RRM2—Nucleotide metabolism—CAT—psoriasis	1.44e-05	0.033	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	1.38e-05	0.0317	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	1.13e-05	0.0261	CbGpPWpGaD
Hydroxyurea—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	1.12e-05	0.0259	CbGpPWpGaD
Hydroxyurea—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	1.11e-05	0.0255	CbGpPWpGaD
Hydroxyurea—RRM1—Fluoropyrimidine Activity—TP53—psoriasis	1.1e-05	0.0253	CbGpPWpGaD
Hydroxyurea—RRM2—G1/S Transition—PCNA—psoriasis	9.48e-06	0.0218	CbGpPWpGaD
Hydroxyurea—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	9.12e-06	0.021	CbGpPWpGaD
Hydroxyurea—RRM2—Fluoropyrimidine Activity—TP53—psoriasis	9.06e-06	0.0208	CbGpPWpGaD
Hydroxyurea—RRM2—Mitotic G1-G1/S phases—PCNA—psoriasis	7.99e-06	0.0184	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	7.35e-06	0.0169	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—PTTG1—psoriasis	7.19e-06	0.0165	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—PTTG1—psoriasis	6.43e-06	0.0148	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—NDUFA5—psoriasis	6.21e-06	0.0143	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	6.17e-06	0.0142	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CYP2S1—psoriasis	5.28e-06	0.0121	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—NDUFA5—psoriasis	5.11e-06	0.0118	CbGpPWpGaD
Hydroxyurea—RRM1—Retinoblastoma (RB) in Cancer—TP53—psoriasis	5.07e-06	0.0117	CbGpPWpGaD
Hydroxyurea—CYP2D6—Biological oxidations—CYP2S1—psoriasis	4.84e-06	0.0111	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	4.78e-06	0.011	CbGpPWpGaD
Hydroxyurea—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	4.7e-06	0.0108	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CYP2S1—psoriasis	4.35e-06	0.00999	CbGpPWpGaD
Hydroxyurea—RRM2—Retinoblastoma (RB) in Cancer—TP53—psoriasis	4.17e-06	0.00959	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	4.09e-06	0.00941	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	3.94e-06	0.00906	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	3.58e-06	0.00822	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	3.06e-06	0.00704	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle, Mitotic—PCNA—psoriasis	2.93e-06	0.00673	CbGpPWpGaD
Hydroxyurea—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	2.79e-06	0.00642	CbGpPWpGaD
Hydroxyurea—RRM1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	2.7e-06	0.00621	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—PCNA—psoriasis	2.62e-06	0.00602	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CARM1—psoriasis	2.58e-06	0.00593	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CARM1—psoriasis	2.12e-06	0.00488	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—CAT—psoriasis	1.59e-06	0.00364	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—CAT—psoriasis	1.31e-06	0.003	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—APOE—psoriasis	1.23e-06	0.00283	CbGpPWpGaD
Hydroxyurea—RRM1—Metabolism—PPARG—psoriasis	1.07e-06	0.00247	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—APOE—psoriasis	1.01e-06	0.00233	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—NDUFA5—psoriasis	9.74e-07	0.00224	CbGpPWpGaD
Hydroxyurea—RRM2—Cell Cycle—TP53—psoriasis	9.63e-07	0.00221	CbGpPWpGaD
Hydroxyurea—RRM2—Metabolism—PPARG—psoriasis	8.84e-07	0.00203	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CYP2S1—psoriasis	8.28e-07	0.0019	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CARM1—psoriasis	4.04e-07	0.00093	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—CAT—psoriasis	2.49e-07	0.000572	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—APOE—psoriasis	1.93e-07	0.000444	CbGpPWpGaD
Hydroxyurea—CYP2D6—Metabolism—PPARG—psoriasis	1.68e-07	0.000387	CbGpPWpGaD
